All.Can Media Coverage – Korea Biomedical Review

‘Efficient cancer care meeting highest patient needs produce best treatment results’ Read the article and interview  (link here) with All.Can CEO Eduardo Pisani  that was published on 15 January 2021 in the Korea Biomedical Review  in light of the recent launch of the All.Can National…


New All.Can National Initiative in Korea

All.Can Korea is the first Asian branch of All.Can International, consisting of patient advocacy groups, healthcare professionals, public health policy experts, legal counsellor, and an industry partner, BMS Pharmaceuticals Korea Ltd. On…

All.Can Sweden – Launch Webinar

Welcome to the All.Can Sweden launch webinar that is taking place on Thursday, December 3rd from 10.00-12.00 CET. To attend the webinar, please click on the following link:

SPCC Webinar Series

All.Can International is delighted to collaborate on a series of webinars promoted by Sharing Progress in Cancer Care (SPCC). The first webinar will be held on 1st December from 18:00…

All.Can statement regarding continuity of cancer care during the COVID-19 pandemic

All.Can wishes to pay tribute, and express its support, to all the healthcare professionals working on the front line in the fight against COVID-19.